                               SEQUENCE LISTING

<110> BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
      ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
 
<120> PROTACS WITH TRANSCRIPTION FACTOR TARGETING MOIETIES

<130> 167688-020502PCT

<140> PCT/US2022/031317
<141> 2022-05-27

<150> 63/245,506
<151> 2021-09-17

<150> 63/194,917
<151> 2021-05-28

<160> 17    

<170> PatentIn version 3.5

<210> 1
<211> 10
<212> DNA
<213> Unknown

<220>
<223> Description of Unknown: 
      NF-Kappa B site sequence


<220>
<221> modified_base
<222> (5)..(6)
<223> a, c, t, g, unknown or other

<400> 1
gggrnnyycc                                                              10


<210> 2
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
acggaccgga aatccggtt                                                    19


<210> 3
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
tacaaagatc aaagggtt                                                     18


<210> 4
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
tggggacttt ccagtttctg gaaagtcccc a                                      31


<210> 5
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
ctagatttcc cgcg                                                         14


<210> 6
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
ctagcgcggg aaat                                                         14


<210> 7
<211> 13
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
ctagcgcgga aat                                                          13


<210> 8
<211> 19
<212> DNA
<213> Unknown

<220>
<223> Description of Unknown: 
      TNF alpha sequence

<400> 8
aacagggggc tttccctcc                                                    19


<210> 9
<211> 19
<212> DNA
<213> Human immunodeficiency virus 1

<400> 9
cgctggggac tttccacgg                                                    19


<210> 10
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
tggggacttt ccagtttctg gaaagtcccc a                                      31


<210> 11
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
tggggacttt ccagtttctg gaaagtcccc a                                      31


<210> 12
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
tggggacttt ccagtttctg gaaagtcccc a                                      31


<210> 13
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 13
ctagatttcc cgcg                                                         14


<210> 14
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 14
ctagatttcc cgcg                                                         14


<210> 15
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 15
tggggacttt ccagtttctg gaaagtcccc a                                      31


<210> 16
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 16
tggggacttt ccagtttctg gaaagtcccc a                                      31


<210> 17
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 17
ctagatttcc cgcg                                                         14


